<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04651140</url>
  </required_header>
  <id_info>
    <org_study_id>Zhang Ying</org_study_id>
    <nct_id>NCT04651140</nct_id>
  </id_info>
  <brief_title>Research on the Effect and Mechanism of Aerobic Exercise on PD</brief_title>
  <official_title>Research on the Effect and Mechanism of Aerobic Exercise on Parkinson's</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Hospital of Jilin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Hospital of Jilin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is expected to recruit patients with primary Parkinson's disease and give them&#xD;
      four consecutive weeks of aerobic exercise to observe its effect on Parkinson's disease and&#xD;
      explore its mechanism&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is expected to recruit patients with primary Parkinson's disease who are&#xD;
      distributed into tremor group and stiff group and give them the same kind of four consecutive&#xD;
      weeks of aerobic exercise to observe its effect on Parkinson's disease and explore its&#xD;
      mechanism&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 13, 2020</start_date>
  <completion_date type="Anticipated">October 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Movement Disorder Society-United Parkinson's Disease Rating Scale (MDS-UPDRS)</measure>
    <time_frame>changes of MDS-UPDRS score from baseline at four weeks</time_frame>
    <description>to assess the motor and nonmotor function of PD,0-200 scores,the higher scores mean lower function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Montreal Cognitive Assessing(MoCA) score</measure>
    <time_frame>changes of MoCA score from baseline at four weeks</time_frame>
    <description>to assess the cognitive function of PD,0-30 scores,the higher scores mean better function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Epworth Sleeping Scale(ESS)</measure>
    <time_frame>changes of ESS score from baseline at four weeks</time_frame>
    <description>to assess the degree of drowsiness, 0-24 scores, the higher scores mean severe drowsiness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-Motor Symptom Scale (NMSS)</measure>
    <time_frame>changes of NMSS score from baseline at four weeks</time_frame>
    <description>to assess the non-motor of PD , 0-120 scores, the higher scores mean severe non-motor damage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cerebral blood variation by Head MRI</measure>
    <time_frame>changes of the cerebral blood from baseline at four weeks</time_frame>
    <description>to assess the cerebral blood variation by head MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cerebral blood flow velocity</measure>
    <time_frame>changes of the cerebral blood flow velocity from baseline at four weeks</time_frame>
    <description>cerebral blood flow velocity is recorded using transcranial Doppler and a servo-controlled plethysmograph respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the level of arterial blood pressure</measure>
    <time_frame>changes of the arterial blood pressure from baseline at four weeks</time_frame>
    <description>arterial blood pressure is recorded using transcranial Doppler and a servo-controlled plethysmograph respectively. Both systolic and diastolic pressures will be assessed during the study period.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the concentration of microRNA in peripheral blood by gene chip</measure>
    <time_frame>changes of microRNA from baseline at four weeks</time_frame>
    <description>to test the the concentration of microRNA in peripheral blood</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Parkinson's Disease</condition>
  <condition>Physical Exercise</condition>
  <arm_group>
    <arm_group_label>Tremor group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the tremor group have tremor as the main clinical manifestation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stiff group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in the tremor group have stiff as the main clinical manifestation</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>aerobic exercise</intervention_name>
    <description>Participants ride an Acon-8650 model exercise bicycle 3 times a week for 1 hour each time for four consecutive weeks</description>
    <arm_group_label>Stiff group</arm_group_label>
    <arm_group_label>Tremor group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants were diagnosed primary PD according to the 2015 MDS diagnostic criteria&#xD;
&#xD;
          -  Participants are between 55 and 65 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe heart&#xD;
&#xD;
          -  liver dysfunction&#xD;
&#xD;
          -  kidney dysfunction&#xD;
&#xD;
          -  severe cognitive dysfunction&#xD;
&#xD;
          -  severe anxiety and depression&#xD;
&#xD;
          -  history of mental illness&#xD;
&#xD;
          -  history of cerebral infarction or ischemic attack in the past three months&#xD;
&#xD;
          -  acute myocardial infarction or acute coronary in the past three months&#xD;
&#xD;
          -  Parkinson's Pulse syndrome&#xD;
&#xD;
          -  medication history (drugs that improve blood circulation in the brain and increase the&#xD;
             excitability of the nervous system)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ying Zhang, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>The First Hospital of Jilin University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>FirstJilinU</name>
      <address>
        <city>Changchun</city>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 8, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2020</study_first_posted>
  <last_update_submitted>December 30, 2020</last_update_submitted>
  <last_update_submitted_qc>December 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Hospital of Jilin University</investigator_affiliation>
    <investigator_full_name>Zhang Ying</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Parkinson's Disease</keyword>
  <keyword>Physical exercise</keyword>
  <keyword>Mechanism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

